Comerica Bank Abb Vie Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Comerica Bank holds 861,858 shares of ABBV stock, worth $155 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

861,858

Previous 877,706 1.81%

Holding current value

$155 Million

Previous $151 Million 13.06%

% of portfolio

0.68%

Previous 0.63%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $2.6 Million - $3.16 Million	-15,848 Reduced 1.81%	861,858 $170 Million
Q2 2024 Aug 15, 2024	SELL	$154.79 - $180.76 $255,713 - $298,615	-1,652 Reduced 0.19%	877,706 $151 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $2.82 Million - $3.21 Million	-17,616 Reduced 1.96%	879,358 $160 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $7.25 Million - $8.17 Million	-52,725 Reduced 5.55%	896,974 $139 Million
Q3 2023 Nov 21, 2023	SELL	$133.59 - $154.65 $197 Million - $229 Million	-1,478,197 Reduced 60.88%	949,699 $142 Million
Q2 2023 Aug 22, 2023	BUY	$132.51 - $164.9 $244 Million - $303 Million	1,837,984 Added 311.57%	2,427,896 $195,000
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $5.66 Million - $6.79 Million	40,922 Added 7.45%	589,912 $0
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $381,827 - $437,930	-2,845 Reduced 0.52%	548,990 $82.8 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $2.85 Million - $3.62 Million	-20,680 Reduced 3.61%	551,835 $82.6 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $2.35 Million - $2.91 Million	-17,770 Reduced 3.01%	572,515 $92.8 Million
Q4 2021 Feb 18, 2022	SELL	$107.43 - $135.93 $2.05 Million - $2.59 Million	-19,056 Reduced 3.13%	590,285 $79.9 Million
Q3 2021 Nov 22, 2021	SELL	$106.4 - $120.78 $8.16 Million - $9.26 Million	-76,709 Reduced 11.18%	609,341 $65.7 Million
Q2 2021 Aug 26, 2021	SELL	$105.21 - $117.21 $2.51 Million - $2.8 Million	-23,903 Reduced 3.37%	686,050 $77.3 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $397,128 - $437,190	-3,882 Reduced 0.54%	709,953 $76.8 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $2.49 Million - $3.36 Million	-30,950 Reduced 4.16%	713,835 $76.5 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $1.38 Million - $1.62 Million	-16,046 Reduced 2.11%	744,785 $65.2 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $3.88 Million - $5.19 Million	52,832 Added 7.46%	760,831 $74.7 Million
Q1 2020 May 01, 2020	SELL	$64.5 - $97.79 $988,591 - $1.5 Million	-15,327 Reduced 2.12%	707,999 $53.9 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $9.74 Million - $12.2 Million	135,089 Added 22.97%	723,326 $64 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $563,545 - $677,542	-8,948 Reduced 1.5%	588,237 $44.5 Million
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $2.97 Million - $3.79 Million	-45,184 Reduced 7.03%	597,185 $0
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $1.93 Million - $2.27 Million	-25,001 Reduced 3.75%	642,369 $0
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $2.77 Million - $3.42 Million	-35,585 Reduced 5.06%	667,370 $51.7 Million
Q3 2018 Nov 01, 2018	SELL	$88.91 - $98.84 $8.47 Million - $9.41 Million	-95,225 Reduced 11.93%	702,955 $58.3 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $3.49 Million - $4.13 Million	-38,868 Reduced 4.64%	798,180 $76.2 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $7.87 Million - $10.5 Million	-85,579 Reduced 9.28%	837,048 $77.9 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $3.38 Million - $3.71 Million	-37,746 Reduced 3.93%	922,627 $97.3 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $67.1 Million - $85.7 Million	960,373	960,373 $87.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account